In this three-part series, expert haemato-oncologists discuss MPNs, considering differences in patient and physician perceptions on the burden of disease, real-world evidence in MF, and how to change your approach based on a patient’s genetic mutations.
MF, myelofibrosis; MPN, myeloproliferative neoplasm.
What is your MPN patient not telling you? Patient and physician perceptions on the burden of myeloproliferative neoplasms (MPNs).Show more
What is REALLY going on in MPNs? Real-world evidence in MPNs.Show more
Which MPN patients do I need to really watch? Molecular variables in prognostic models for patients with myeloproliferative neoplasms (MPNs).Show more